PMID: 6164466Mar 1, 1981Paper

VAB-4 combination chemotherapy in the treatment of metastatic testis tumors

Cancer
D VugrinR B Golbey

Abstract

Forty-two patients with advanced testis carcinoma without previous chemotherapy were treated with VAB-4, and 41 were evaluable. The program consisted of three in-hospital inductions 16 weeks apart, and outpatient treatments every three weeks. Of the patients, 80% achieved complete remissions (CR). Chemotherapy alone induced CR in 61%, partial remissions (PR), in 24% and minor response (MR), in 15%. An additional 20% of patients (six PRs and 2 MRs) achieved CR following resection of residual tumor deposits. With a median follow-up of 27 months, the median duration of CR has not been reached. Of those achieving CR to chemotherapy alone, 12% had relapses. Bulk and extent of metastatic disease, histology of primary tumor, and tumor markers at the beginning of therapy influenced the frequency of CR. Of those with minimal disease, 90% achieved CR. The CR rate was 67% for those with advanced thoracic disease and 29% for those with advanced abdominal disease. Patients who had embryonal carcinoma and those who had no elevation of alpha-fetoprotein had a higher frequency of CRs. Myelosuppression with a leukocyte count drop less than 1000/mm3 occurred in three patients, and no patient had chronic renal failure or pulmonary fibrosis. One p...Continue Reading

Citations

Mar 1, 1990·Journal of Surgical Oncology·Y Hannun, D Vugrin
Jan 1, 1992·Cancer Chemotherapy and Pharmacology·R A ChisholmR T Oliver
Apr 1, 1996·Critical Reviews in Oncology/hematology·S CulineJ P Droz
Apr 26, 2002·International Journal of Urology : Official Journal of the Japanese Urological Association·Tsuneharu Miki, Masahiro Nakao
Aug 1, 1984·Australasian Radiology·K W Tiver, A O Langlands
Sep 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·A B ClarksonA Sjoerdsma
Dec 1, 1982·European Journal of Cancer & Clinical Oncology·R A StahelH P Honegger
Jul 1, 1986·Journal of Surgical Oncology·M SteinerE Robinson
Oct 1, 1985·British Journal of Urology·R E TaylorM A Cornbleet
May 9, 2007·The Urologic Clinics of North America·G Varuni Kondagunta, Robert J Motzer
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Madhu MazumdarGeorge J Bosl
Aug 15, 1981·Cancer·T F ReynoldsR B Golbey
Aug 15, 1982·Cancer·B R PaschalC L Spurr
Mar 8, 1986·British Medical Journal·R T Oliver
Jan 1, 1985·Acta Radiologica. Oncology·O Dahl
Jun 25, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Samuel A FuntGeorge J Bosl
Jan 1, 1983·Scandinavian Journal of Urology and Nephrology·N BrünnerC M Madsen
Sep 1, 1983·The Journal of Urology·J J BredaelW F Whitmore

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.